Mirador Therapeutics
- Health & Biotech
- San Diego, CA, US
- Founded 2024
- Private
- miradortx.com
Develops precision medicines for immune-mediated and immuno-fibrotic diseases through a multi-asset clinical pipeline.
$250MEquity raised in 2025–20262025 — · 2026 $250M · 1 equity round
$250MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 2 sources
Earlier rounds not yet sourced. Mirador Therapeutics was founded in 2024 and raised before 12 Jan 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series BAmount$250MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 6
- ARCH Venture Partners
- Blue Owl
- Fidelity
- Point72
- T. Rowe Price
- Venrock
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
DatabricksEnterprise · $10B in 2025–2026Shared: T. Rowe Price, Fidelity +1Parabilis MedicinesHealth · $975M in 2025–2026Shared: T. Rowe Price, Fidelity +1KardiganHealth · $554M in 2025–2026Shared: T. Rowe Price, Fidelity +1AnthropicAI Labs · $113B in 2025–2026Shared: T. Rowe Price, FidelityBending SpoonsConsumer · $1.3B in 2025–2026Shared: T. Rowe Price, FidelityOllin BiosciencesHealth · $430M in 2025–2026Shared: T. Rowe Price, ARCH Venture Partners
Also in the San Diego hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Mirador Therapeutics and its logo are trademarks of their owners, used here for identification only.
